The Association between Short Telomere Length and Cardiovascular Disease
Cytogenetic and Genome Research · 2024
DOI: 10.1159/000542795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytogenetic and Genome Research, 2024. Verfasst von Persefoni Fragkiadaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Toxicology and Forensic Sciences, Medical School, University of Crete, Heraklion, Greece, persefoni.f@gmail.com. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Telomere, Telomere Shortening. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
Telomeres, repetitive DNA sequences at chromosome ends, shorten with cell division, countered by telomerase. Short telomeres are linked to cardiovascular disease (CVD), alongside its risk factors like aging, hypertension, diabetes, obesity, inactivity, and smoking. Many studies have claimed the implication of telomere length (TL) in cardiac diseases. This study examined TL’s impact on heart conditions using quantitative fluorescence in situ hybridization (Q-FISH) technology.
Methods
Thirteen CVD patients (nine men and four women) aged 30–70 years and aged-matched healthy participants from the BIOTEL population TL database, were included in the study. Each chromosome’s TL from peripheral blood cells was measured using metaphase Q-FISH. An independent sample t test was used to compare participants’ mean or median TL with various medical factors and habits.
Results
The mean TL of whole and short telomeres in cardiac disease patients was lower compared to aged-matched healthy controls; however, there was no statistical significance due to the limited patient sample. The mean TL of short telomeres in cardiac disease patients showed a remarkable decline with advanced age. Accordingly, the mean TL of whole and short telomeres in patients with cardiac diseases showed a similar reduced trend.
Conclusion
In our study, shorter TL was observed in cardiac disease patients compared to those of healthy controls by using metaphase Q-FISH. However, more cases need to be studied to elucidate the use of TL as a potential biomarker for the diagnosis of patients with CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Toxicology and Forensic Sciences, Medical School, University of Crete, Heraklion, Greece, persefoni.f@gmail.com.
- Lifeplus S.A., Heraklion, Greece, persefoni.f@gmail.com.
- Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Phenotypos Lab, Athens, Greece.
- Laboratory of Toxicology and Forensic Sciences, Medical School, University of Crete, Heraklion, Greece.
- Lifeplus S.A., Heraklion, Greece.
Zitieren
APA
Fragkiadaki, P., Apetroaei, M. M., Kouvidi, E., Vakonaki, E., Renieri, E., Fragkiadoulaki, I., Spanakis, M., Baliou, S., Alegakis, A., & Tsatsakis, A. (2024). The Association between Short Telomere Length and Cardiovascular Disease. Cytogenetic and Genome Research. https://doi.org/10.1159/000542795
Vancouver
Fragkiadaki P, Apetroaei MM, Kouvidi E, Vakonaki E, Renieri E, Fragkiadoulaki I, et al. The Association between Short Telomere Length and Cardiovascular Disease. Cytogenetic and Genome Research. 2024. doi:10.1159/000542795
BibTeX
@article{Fragkiadaki2024,
author = {Fragkiadaki, Persefoni and Apetroaei, Miruna-Maria and Kouvidi, Elisavet and Vakonaki, Elena and Renieri, Elissavet and Fragkiadoulaki, Irene and Spanakis, Marios and Baliou, Stella and Alegakis, Athanasios and Tsatsakis, Aristidis},
title = {The Association between Short Telomere Length and Cardiovascular Disease},
journal = {Cytogenetic and Genome Research},
year = {2024},
doi = {10.1159/000542795}
}
EUVIMED